Takaaki Akasaka
Overview
Explore the profile of Takaaki Akasaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakatani T, Shiosakai K, Hashimoto T, Shionoya M, Akasaka T, Toyama K, et al.
J Palliat Med
. 2022 Dec;
26(6):768-775.
PMID: 36579915
The opioid analgesic hydromorphone has a low renal excretion ratio; however, exposure after oral administration is several times higher in those with moderate or severe renal impairment. We evaluated the...
2.
Uchida H, Nakajima H, Hashimoto M, Nakamura A, Nunoue T, Murakami K, et al.
Adv Ther
. 2022 Sep;
39(11):5158-5175.
PMID: 36070133
Introduction: Clinical data of esaxerenone in hypertensive patients with diabetic kidney disease (DKD) are lacking. We evaluated the efficacy and safety of esaxerenone in patients with DKD and an inadequate...
3.
Sueta D, Yamamoto E, Usuku H, Suzuki S, Nakamura T, Matsui K, et al.
Circ Rep
. 2022 Feb;
4(2):99-104.
PMID: 35178486
The complication of left ventricular (LV) hypertrophy (LVH) is associated with increased incidence of major cardiovascular events. Hypertension is an independent risk factor among several factors contributing to the development...
4.
Hamasuna R, Hanzawa H, Moritomo A, Matsumoto M, Aono H, Tomisaki I, et al.
J Infect Chemother
. 2021 Nov;
28(3):377-383.
PMID: 34836778
Introduction: The mechanisms of fluoroquinolone-resistance of Mycoplasma genitalium were analysed by a new method. Methods: M. genitalium strains from urinary sediments of patients with urethritis were isolated and examined antimicrobial...
5.
Ikushima I, Akasaka T, Morishima Y, Takita A, Motohashi T, Kimura T
Thromb J
. 2020 Jun;
18:10.
PMID: 32536828
Background: Dual therapy with a direct oral anticoagulant (DOAC) plus a P2Y receptor inhibitor is recommended in patients with nonvalvular atrial fibrillation who undergo percutaneous coronary intervention. Thus, we evaluated...
6.
Yamashita T, Hagii J, Morishima Y, Akasaka T, Matsumoto T, Kimura T
Thromb J
. 2019 Mar;
17:3.
PMID: 30814914
Background: This study involved a sensory evaluation of edoxaban orally disintegrating (OD) tablets in patients with nonvalvular atrial fibrillation who had been receiving the existing edoxaban film-coated tablets before the...
7.
Saga T, Akasaka T, Takase H, Tanaka M, Sato K, Kaku M
Int J Antimicrob Agents
. 2007 Mar;
29(6):738-9.
PMID: 17374476
No abstract available.
8.
Otani T, Tanaka M, Ito E, Kurosaka Y, Murakami Y, Onodera K, et al.
Antimicrob Agents Chemother
. 2003 Nov;
47(12):3750-9.
PMID: 14638477
The antibacterial activities of DK-507k, a novel quinolone, were compared with those of other quinolones: ciprofloxacin, gatifloxacin, levofloxacin, moxifloxacin, sitafloxacin, and garenoxacin (BMS284756). DK-507k was as active as sitafloxacin and...
9.
Tanaka M, Yamazaki E, Chiba M, Yoshihara K, Akasaka T, Takemura M, et al.
Antimicrob Agents Chemother
. 2002 Feb;
46(3):904-8.
PMID: 11850285
The antibacterial activity of DQ-113, formerly D61-1113, was compared with those of antibacterial agents currently available. MICs at which 90% of the isolates tested are inhibited (MIC90s) of DQ-113 against...